BioVU Archive — Page 2 of 8
-
August 13, 2024
$3.4 million research grant targets risk of heart attack, stroke
Making innovative use of observational data, researchers hope to gain new understanding of patient risk and identify existing drugs to lower risk. -
June 25, 2024
Gene variant may underlie diabetes disparities: study
The study was the largest ancestry-stratified, genetic estimation of the heritability of diabetic retinopathy conducted to date and included an unprecedented number of individuals of non-Hispanic African ancestry — more than 46,000. -
June 3, 2024
Genetic variation associated with low white blood cell count impacts clinical decisions
People whose white blood cell levels are near the edge of the “healthy” reference range will hit a clinical decision point that has consequences such as diagnostic procedures and altered treatments. -
May 15, 2024
Treatment-resistant depression linked to body mass index: study
Genetic factors are a small but significant contributor to severe depression that does not respond to standard therapy, according to researchers at Vanderbilt University Medical Center and Massachusetts General Hospital. -
May 1, 2024
Study finds 500 new blood pressure genes
An analysis of the genomes of more than 1 million people of European ancestry, conducted by several of the world’s leading genomic centers, including Vanderbilt University Medical Center, has identified more than 2,000 independent genetic signals for blood pressure. -
March 26, 2024
Beethoven’s genes reveal low predisposition for beat synchronization
What the exceptional composer's DNA tells us about genetics -
February 21, 2024
International genetic study of glaucoma implicates vascular and cancer-related genes
An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.